
Summary for Tradename: benicar
|
|
Latest news for BENICARReportlinker Adds Hypertension: Competing Treatments and Market Entry Considerations7 September 2010, 12:44 pm GI Dynamics announces data on EndoBarrier therapy for type 2 diabetes, obesity7 September 2010, 8:12 am Courtesy of Yahoo News |
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Patent Expiration | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|
| Daiichi Sankyo | BENICAR | olmesartan medoxomil | 021286 | Apr 25, 2002 | RX | No | APR 25,2007 | ||
| Daiichi Sankyo | BENICAR | olmesartan medoxomil | 021286 | Apr 25, 2002 | RX | No | 5,616,599 | APR 25,2016 | |
| Daiichi Sankyo | BENICAR | olmesartan medoxomil | 021286 | Apr 25, 2002 | RX | No | 6,878,703 | NOV 19,2021 |
| Drugname | Dosage | Strength | RLD | Submissiondate |
| olmesartan medoxomil and hydrochlorothiazide | Tablets | 20 mg/12.5 mg | Benicar HCT | 5/11/2007 |
| olmesartan medoxomil and hydrochlorothiazide | Tablets | 40 mg/12.5 mg and 40 mg/25 mL | Benicar HCT | 2/15/2007 |
| olmesartan medoxomil | Tablets | 5 mg, 20 mg and 40 mg | Benicar | 4/25/2006 |
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.